# EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

> **NCT00107445** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 60 (actual)

## Conditions studied

- Primary Peritoneal Cavity Cancer
- Stage I Endometrial Carcinoma
- Stage I Ovarian Epithelial Cancer
- Stage IA Cervical Cancer
- Stage IB Cervical Cancer
- Stage II Endometrial Carcinoma
- Stage II Ovarian Epithelial Cancer
- Stage IIA Cervical Cancer
- Stage IIB Cervical Cancer
- Stage III Cervical Cancer
- Stage III Endometrial Carcinoma
- Stage III Ovarian Epithelial Cancer
- Stage IV Endometrial Carcinoma
- Stage IV Ovarian Epithelial Cancer
- Stage IVA Cervical Cancer
- Stage IVB Cervical Cancer

## Interventions

- **DRUG:** EF5

## Key facts

- **NCT ID:** NCT00107445
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-09
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107445, "EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00107445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*